These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920 [TBL] [Abstract][Full Text] [Related]
24. [Analysis of 66 cases received hematopoietic stem cell transplantation from unrelated donors]. Chen YH; Huang XJ; Chen H; Xu LP; Liu DH; Jiang Q; Zhang YC; Han W; Gao ZY; Wang JZ; Liu KY; Wu T; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):656-60. PubMed ID: 16620550 [TBL] [Abstract][Full Text] [Related]
25. Selective recruitment of stem cell donors with rare human leukocyte antigen phenotypes. Schmidt AH; Stahr A; Baier D; Schumacher S; Ehninger G; Rutt C Bone Marrow Transplant; 2007 Nov; 40(9):823-30. PubMed ID: 17724442 [TBL] [Abstract][Full Text] [Related]
26. Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup. Rosenmayr A; Hartwell L; Egeland T; Bone Marrow Transplant; 2003 Apr; 31(7):539-45. PubMed ID: 12692618 [TBL] [Abstract][Full Text] [Related]
27. [Economic evaluation of the organization of a registry of haematopoietic stem cell donors]. Feve F; Cambon-Thomsen A; Eliaou JF; Gourraud PA; Raffoux C; Florens JP Rev Epidemiol Sante Publique; 2007 Aug; 55(4):275-84. PubMed ID: 17597327 [TBL] [Abstract][Full Text] [Related]
28. The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Tiercy JM; Nicoloso G; Passweg J; Schanz U; Seger R; Chalandon Y; Heim D; Güngör T; Schneider P; Schwabe R; Gratwohl A Bone Marrow Transplant; 2007 Sep; 40(6):515-22. PubMed ID: 17646842 [TBL] [Abstract][Full Text] [Related]
29. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation. Ballen KK; King RJ; Chitphakdithai P; Bolan CD; Agura E; Hartzman RJ; Kernan NA Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):2-7. PubMed ID: 18721774 [TBL] [Abstract][Full Text] [Related]
30. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M; Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656 [TBL] [Abstract][Full Text] [Related]
31. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Karanes C; Nelson GO; Chitphakdithai P; Agura E; Ballen KK; Bolan CD; Porter DL; Uberti JP; King RJ; Confer DL Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):8-15. PubMed ID: 18721775 [TBL] [Abstract][Full Text] [Related]
32. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study. Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143 [TBL] [Abstract][Full Text] [Related]
33. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. Madrigal A; Shaw BE Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of the pretransplantation phase of the hemopoietic stem cell program in a tertiary hospital. Márquez Malaver FJ; Espigado Tocino I; Balsalobre López P; Carmona González M; Parody Ruiz-Berdejo R; Perez-Hurtado de Mendoza JM; Urbano Ispizua A Transplant Proc; 2008 Nov; 40(9):3099-101. PubMed ID: 19010206 [TBL] [Abstract][Full Text] [Related]
35. Strategies for new donor typing based on donor HLA type or donor characteristics. Little AM; Jindra P; Raffoux C Tissue Antigens; 2007 Apr; 69 Suppl 1():8-9. PubMed ID: 17445153 [TBL] [Abstract][Full Text] [Related]
36. Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health. Sacchi N; Costeas P; Hartwell L; Hurley CK; Raffoux C; Rosenmayr A; Greinix H; Bone Marrow Transplant; 2008 Jul; 42(1):9-14. PubMed ID: 18362904 [TBL] [Abstract][Full Text] [Related]
37. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia. Sierra J; Martino R; Sánchez B; Piñana JL; Valcárcel D; Brunet S Bone Marrow Transplant; 2008 Mar; 41(5):425-37. PubMed ID: 18209727 [TBL] [Abstract][Full Text] [Related]
38. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. MacMillan ML; Davies SM; Nelson GO; Chitphakdithai P; Confer DL; King RJ; Kernan NA Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):16-22. PubMed ID: 18721776 [TBL] [Abstract][Full Text] [Related]
39. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies. Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633 [TBL] [Abstract][Full Text] [Related]
40. Hematopoietic cell transplantation for correction of primary immunodeficiencies. Filipovich A Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S49-S52. PubMed ID: 18724301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]